Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · IEX Real-Time Price · USD
+0.11 (1.93%)
At close: Feb 23, 2024, 4:00 PM
-0.08 (-1.38%)
After-hours: Feb 23, 2024, 7:48 PM EST

Amneal Pharmaceuticals Revenue

Amneal Pharmaceuticals had revenue of $2.39B in the twelve months ending September 30, 2023, with 11.54% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $620.04M with 13.65% year-over-year growth. In the year 2022, Amneal Pharmaceuticals had annual revenue of $2.21B with 5.67% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.78B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20222.21B118.64M5.67%
Dec 31, 20212.09B101.15M5.08%
Dec 31, 20201.99B366.15M22.51%
Dec 31, 20191.63B-36.62M-2.20%
Dec 31, 20181.66B629.34M60.88%
Dec 31, 20171.03B15.43M1.52%
Dec 31, 20161.02B151.95M17.54%
Dec 31, 2015866.28M80.66M10.27%
Dec 31, 2014785.62M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owens & Minor 10.33B
InMode 492.05M
Veracyte 343.15M
Agios Pharmaceuticals 26.82M
Morphic Holding 521.00K
Inhibrx 440.00K
Revenue Rankings